Pfizer reiterated its annual revenue forecast of $8 billion from the sale of COVID-19 shot Comirnaty and anti-viral treatment ...
MINNEAPOLIS — After more than 13 billion COVID vaccines given around the world, the largest studies to date point to the ...
71.3%. The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.
ORLANDO, Fla. – A traffic stop in downtown Orlando ended in a deadly police shooting, according to authorities. Orlando Police Chief Eric Smith, who held a news conference about the shooting ...
House prices fell for a second month in a row as mortgage lenders put up race, according to a lender. Property values dropped ...
US stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two ...
Pfizer ( PFE-N) was up after lifted its annual profit forecast on Wednesday, and reported first-quarter results that topped ...
In this phase 2–3 trial, we randomly assigned adults who had confirmed Covid-19 with symptom onset within the past 5 days in a 1: ... writers (funded by Pfizer) under direction from the authors.
But with the healthcare stock down more than 60% from its 52-week high of $11.36 and at a market cap of around $620 million, has the stock become cheap enough that it's worth it f ...
A late-stage trial of Pfizer’s RSV vaccine showed promising results in adults under 60 years old, suggesting the shot could help people ... children ages 2 to 17. 9.5%. That’s how many adults ...
On Monday, US-based Pfizer and ... vaccine for children 5 to 11 years old, and we plan to submit them to the FDA and other regulators with urgency.” Under Hong Kong’s coronavirus restrictions ...